MENADIONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Menadione, and what generic alternatives are available?
Menadione is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in MENADIONE is menadione. There is one drug master file entry for this compound. Additional details are available on the menadione profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MENADIONE?
- What are the global sales for MENADIONE?
- What is Average Wholesale Price for MENADIONE?
Summary for MENADIONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 159 |
| Clinical Trials: | 5 |
| Patent Applications: | 3,143 |
| DailyMed Link: | MENADIONE at DailyMed |
Recent Clinical Trials for MENADIONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Scotmann Pharmaceuticals | Phase 3 |
| University of Health Sciences Lahore | Phase 3 |
| Tanta University | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for MENADIONE
US Patents and Regulatory Information for MENADIONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | MENADIONE | menadione | TABLET;ORAL | 002139-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
